Browse Catapults
  • Catapult Network
  • Cell and Gene Therapy
  • Compound Semiconductor Applications
  • Connected Places
  • Digital
  • Energy Systems
  • High Value Manufacturing
  • Medicines Discovery
  • Offshore Renewable Energy
  • Satellite Applications
  • Innovate UK
Innovate UK - Catapult Logo
  • About us
    • About Us
    • Our Centres
    • Catapult CEOs
  • Our Work
    • Case Studies
    • Our Impact
  • Work with us
    • Business & Industry
    • Research & Academia
    • Careers
  • Media
    • News
    • Publications
    • Events
    • Podcast
  • Contact
Innovate UK - UKRI
  • About Us
    • About Us
    • Our Centres
    • Catapult CEOs
  • Our Work
    • Case studies
    • Our Impact
  • Work with us
    • Business & Industry
    • Research & Academia
    • Careers
  • Media
    • News
    • Publications
    • Events
    • Podcast
  • Contact
  • Policy & Public Affairs Officer
  • Accessibility Policy
  • Catapulting Growth Event Photography
  • https://www.ukri.org/councils/innovate-uk/

Case Studies from across the Catapults

Themes
  • Skills (11),
  • Regional growth (18),
  • Highlights (27),
  • Equality, Diversity and Inclusion (12),
  • International (12),
  • Academic engagement (19),
  • Net Zero (23),
  • Health (18),
  • Digital technologies (18),
  • Business growth (29),
  • Supply chains (6),
  • Leveraging Investment (19),
Themes
  • Skills
  • Regional growth
  • Highlights
  • Equality, Diversity and Inclusion
  • International
  • Academic engagement
  • More
  • Net Zero
  • Health
  • Digital technologies
  • Business growth
  • Supply chains
  • Leveraging Investment
Catapults
  • Cross-Catapult (2),
  • Cell and Gene Therapy (15),
  • Compound Semiconductor Applications (13),
  • Connected Places (14),
  • Digital (15),
  • Energy Systems (14),
  • High Value Manufacturing (17),
  • Medicines Discovery (14),
  • Offshore Renewable Energy (15),
  • Satellite Applications (14),
Catapults (Reset)
Cross-Catapult Cell and Gene Therapy Compound Semiconductor Applications Connected Places Digital Energy Systems High Value Manufacturing
Medicines Discovery
Offshore Renewable Energy Satellite Applications
Medicines Discovery
 alt=
Case Study
How do we supercharge and sustain skills in UK Life Sciences?
Medicines Discovery Catapult is reshaping drug discovery for patient benefit by transforming great UK science into better treatments through partnership. The life sciences industry is critical to the UK’s health, wealth, and resilience. Attracting, recruiting, training, and retaining a skilled workforce is key to ongoing success in this critical sector.
Read more
Medicines Discovery
Case Study
How do we supercharge and sustain skills in UK Life Sciences?
Medicines Discovery Catapult is reshaping drug discovery for patient benefit by transforming great UK science into better treatments through partnership. The life sciences industry is critical to the UK’s health, wealth, and resilience. Attracting, recruiting, training, and retaining a skilled workforce is key to ongoing success in this critical sector.
Read more
Medicines Discovery
Case Study
Bolstering the North West’s position as a life science powerhouse
Medicines Discovery Catapult is driving regional growth in the North West of England, supporting the region’s fast-growing and increasingly significant life science industry.
Read more
Medicines Discovery
Case Study
Transforming UK medical imaging
The Medicines Discovery Catapult is working to ensure the UK remains a world leader in Positron Emission Tomography (PET) Imaging, a data-rich non-invasive imaging modality that offers huge potential across the life sciences and is highly amenable to advances in AI.
Read more
Medicines Discovery
 alt=
Case Study
Alchemab Therapeutics secures private funding for new treatments following collaboration
In 2021 Alchemab and Medicines Discovery Catapult (MDC) collaborated on a Huntington’s disease focussed project, which supported Alchemab in securing significant private investment. 
Read more
Medicines Discovery
 alt=
Case Study
The Psychiatry Consortium – exploring new treatments for mental health conditions
Medicines discovery for challenging diseases requires a collaborative approach with a patient focus. In 2019 the Medicines Discovery Catapult established the Psychiatry Consortium as one of its patient focussed partnerships. It is a strategic collaboration of two leading medical research charities and seven international pharmaceutical companies, focusing on the unmet therapeutic needs of people living with mental health conditions.
Read more
Medicines Discovery
 alt=
Case Study
Launch of a drug discovery consortium to address the unmet therapeutic needs of people living with mental health conditions
The Psychiatry Consortium is a £4 million international collaboration between seven global pharmaceutical companies and two leading medical research charities, convened and managed by Medicines Discovery Catapult, to support high-value drug discovery projects that address the unmet therapeutic needs of people living with mental health conditions, including psychiatric symptoms associated with dementia.
Read more
Medicines Discovery
Case Study
Launch of a drug discovery consortium to address the unmet therapeutic needs of people living with mental health conditions
The Psychiatry Consortium is a £4 million international collaboration between seven global pharmaceutical companies and two leading medical research charities, convened and managed by Medicines Discovery Catapult, to support high-value drug discovery projects that address the unmet therapeutic needs of people living with mental health conditions, including psychiatric symptoms associated with dementia.
Read more
Medicines Discovery
 alt=
Case Study
Highlighting the role of women in science and innovation
By championing innovative life science technology and new approaches, Medicines Discovery Catapult is supporting UK innovators to succeed. Medicines Discovery Catapult recognises that diversity in the workforce underpins the creative and innovative thinking essential for success in this sector.
Read more
Medicines Discovery
Case Study
Highlighting the role of women in science and innovation
By championing innovative life science technology and new approaches, Medicines Discovery Catapult is supporting UK innovators to succeed. Medicines Discovery Catapult recognises that diversity in the workforce underpins the creative and innovative thinking essential for success in this sector.
Read more
Medicines Discovery
Case Study
International biobank provides database for cancer researchers worldwide
Medicines Discovery Catapult collaborated with Manchester University to create a sustainable model for a biorepository providing a critical data for researchers investigating patient side-effects from radiotherapy.
Read more
Medicines Discovery
Case Study
Innovative treatments for a longer healthy, independent life
Figures show that we are spending more of our lives in poor health. In response, a national network is bringing together scientific expertise from across the UK to shed new light on the ageing process and help us stay healthy for longer.
Read more
Medicines Discovery
 alt=
Case Study
Mobilising national high scale COVID-19 testing
In March 2020, the UK government announced the launch of a national testing effort to support the UK’s fight against coronavirus via the establishment of a network of high-scale testing laboratories, known as “Lighthouse Labs”.
Read more
Medicines Discovery
 alt=
Case Study
Developing new treatments to prevent thrombosis
LUNAC Therapeutics, a UK based drug discovery company, together with the Medicines Discovery Catapult and the University of Leeds, are working on the development of an innovative first-in-class anticoagulant treatment drug with minimal bleeding risk.
Read more
Medicines Discovery
 alt=
Case Study
Discovery Services platform boosts UK life sciences R&D and international competitiveness
The Medicines Discovery Catapult Virtual R&D Discovery Services platform helps match UK SMEs to access medicines and drug discovery services and state-of-the-art equipment, enabling deeper market penetration and access to a wider network of customers.
Read more
Medicines Discovery
Case Study
Discovery Services platform boosts UK life sciences R&D and international competitiveness
The Medicines Discovery Catapult Virtual R&D Discovery Services platform helps match UK SMEs to access medicines and drug discovery services and state-of-the-art equipment, enabling deeper market penetration and access to a wider network of customers.
Read more
Page 1 of 1

Connect with us

  • in
  • x
Helpful links
  • News
  • Supercharging Innovation Podcast
Useful links
  • Our Work
  • Work with us
  • About Us
  • © 2025 Catapult Network
  • All Rights Reserved

© 2025 Copyright Catapult Network

Terms and Conditions

Privacy Policy

Accessibility Policy

Contact